SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject4/10/2003 3:01:44 PM
From: nigel bates   of 625
 
Wellington Management Reports 7% Cambridge Antibody Stake
Thursday April 10, 12:48 pm ET
WASHINGTON -(Dow Jones)- Wellington Management Co. LLP holds a 7.05% stake in Cambridge Antibody Technology Group PLC, according to a filing Thursday with the Securities and Exchange Commission (News - Websites).
Wellington held 2,562,400 Cambridge Antibody shares after acquiring 800,064 shares. Details of the transaction weren't provided in the filing.
Wellington notified Cambridge Antibody of its holdings Tuesday, the filing said.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext